Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y M Centifanto-Fitzgerald

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Experimental Eye Research|November 1, 1982
Virus proteins in herpetic keratitisY M Centifanto-Fitzgerald, T Fenger, H E Kaufman
Infection and Immunity|March 1, 1982
Initial herpes simplex virus type 1 infection prevents ganglionic superinfection by other strainsY M Centifanto-Fitzgerald, E D Varnell, H E Kaufman
Ophthalmology|June 1, 1983
Herpes simplex keratitisH E Kaufman, Y M Centifanto-Fitzgerald, E D Varnell
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|May 1, 1985
Herpes simplex virus latency in the rabbit trigeminal ganglia: ganglionic superinfectionY M Centifanto-Fitzgerald, M Rayfield, P Y Tian, et al.
Antiviral Research|December 1, 1984
Virus chemotherapy: antiviral drugs and interferonH E Kaufman, E D Varnell, Y M Centifanto-Fitzgerald, et al.
Investigative Ophthalmology & Visual Science|August 1, 1984
Analysis of viral DNA in isolates from patients with recurrent herpetic keratitisP A Asbell, Y M Centifanto-Fitzgerald, J W Chandler, et al.
The Journal of Experimental Medicine|February 1, 1982
Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNAY M Centifanto-Fitzgerald, T Yamaguchi, H E Kaufman, et al.
Experimental Eye Research|November 1, 1982
The role of herpes simplex virus secreted glycoproteins in herpetic keratitisR Smeraglia, J Hochadel, E D Varnell, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1983
Oral antiviral drugs in experimental herpes simplex keratitisH E Kaufman, E D Varnell, Y M Centifanto-Fitzgerald, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Experimental Eye Research|November 1, 1982
Virus proteins in herpetic keratitisY M Centifanto-Fitzgerald, T Fenger, H E Kaufman
Infection and Immunity|March 1, 1982
Initial herpes simplex virus type 1 infection prevents ganglionic superinfection by other strainsY M Centifanto-Fitzgerald, E D Varnell, H E Kaufman
Ophthalmology|June 1, 1983
Herpes simplex keratitisH E Kaufman, Y M Centifanto-Fitzgerald, E D Varnell
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|May 1, 1985
Herpes simplex virus latency in the rabbit trigeminal ganglia: ganglionic superinfectionY M Centifanto-Fitzgerald, M Rayfield, P Y Tian, et al.
Antiviral Research|December 1, 1984
Virus chemotherapy: antiviral drugs and interferonH E Kaufman, E D Varnell, Y M Centifanto-Fitzgerald, et al.
Investigative Ophthalmology & Visual Science|August 1, 1984
Analysis of viral DNA in isolates from patients with recurrent herpetic keratitisP A Asbell, Y M Centifanto-Fitzgerald, J W Chandler, et al.
The Journal of Experimental Medicine|February 1, 1982
Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNAY M Centifanto-Fitzgerald, T Yamaguchi, H E Kaufman, et al.
Experimental Eye Research|November 1, 1982
The role of herpes simplex virus secreted glycoproteins in herpetic keratitisR Smeraglia, J Hochadel, E D Varnell, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1983
Oral antiviral drugs in experimental herpes simplex keratitisH E Kaufman, E D Varnell, Y M Centifanto-Fitzgerald, et al.
Pageof 1